Immediate Reactions
Develop within minutes to hours post-antigen exposure.
Includes Type I, Type II, Type III hypersensitivities.
Also known as anaphylactic hypersensitivity; commonly occur after allergen exposure.
Key components:
IgE: Involved in type I hypersensitivity response.
Mast Cells: Release histamine and other mediators upon activation.
Basophils: Similar function to mast cells, involved in allergic responses.
Eosinophils: Involved in combating parasites and contribute to allergic inflammation.
Type I Hypersensitivity
Example: Urticaria (hives) characterized by wheal and flare.
Positive skin test shows wheal and flare at allergen application site.
Transfusion Reactions: Mediated by antibody-antigen interactions; small antigen-antibody complexes precipitate and deposit in tissues.
Type IV Hypersensitivity
Cell-Mediated/Delayed Hypersensitivity: Involves Th1 cells and macrophages.
Skin Testing for Delayed Hypersensitivity: Mantoux method identifies previous exposure.
Type I Hypersensitivity Testing (In Vivo Skin Tests)
Allergens induce IgE production which binds mast cells and basophils, causing degranulation and allergic symptoms.
Clinical Examples of Type II Hypersensitivity
Hemolytic disease of the newborn (HDN).
Autoimmune hemolytic anemia.
Type III Hypersensitivity
Small immune complexes with IgG or IgM precipitate in tissues.
Example: Tuberculosis test (PPD); a positive test shows induration.
Type II Hypersensitivity: IgG and IgM bind cell surface antigens causing cell damage or dysfunction through various mechanisms (complement lysis, opsonization, ADCC).
Systemic Lupus Erythematosus (SLE)
Causes immune complex deposition and inflammation (neutrophils release enzymes leading to tissue injury).
Common symptoms: Skin rashes (80% of patients), butterfly rash is a key sign.
Laboratory Tests for SLE:
ANA Testing: Anti-nuclear antibodies are often present.
Fluorescent ANA Test:
Homogeneous pattern indicates antibodies to dsDNA, histones common in SLE.
Speckled pattern suggests anti-ENA antibodies, typical in SLE and scleroderma.
Nucleolar pattern indicates antibodies to RNA and RNP, seen mainly in scleroderma.
IIF with Crithidia luciliae: Detects antibodies against a circular organelle containing double-stranded DNA.
Laboratory Testing for Rheumatoid Arthritis (RA)
ANAs present in approximately 40% of RA patients, commonly directed against RNP.
Granulomatosis with Polyangiitis (Wegener's granulomatosis)
Organ-specific autoimmune disease, inflames small- to medium-sized blood vessels.
Commonly develops systemic disease affecting multiple organs.
Neutrophils activated by antibodies to cytoplasmic proteins like proteinase 3 cause vascular endothelial damage.
Hashimoto's Thyroiditis (TPO, Tg antibodies present).
Multiple Sclerosis (MS): Involves central nervous system's inflammation/damage.
Goodpasture's Syndrome: Antibodies against glomerular basement membrane cause kidney and lung damage.
Host-Microbe Relationships
Commensalistic Relationships: No harm or benefit to organisms involved.
Illnesses of Acute Group A Strep Infection
Can cause upper respiratory tract infections leading to rheumatic fever or glomerulonephritis if untreated.
Poststreptococcal Glomerulonephritis: Follows strep skin or throat infections.
Helicobacter Pylori Testing
CLOTest: Biopsy tissue tested for urease presence; indicates infection.
Mycoplasma Pneumoniae: Known colloquially as “walking pneumonia.”
Spirochete Diseases
Include Syphilis, Lyme disease, and Relapsing fever.
Stages of Syphilis:
Primary: Chancre development.
Tertiary: Severe symptoms arise—gummas, cardiovascular issues, neurosyphilis.
Laboratory Diagnosis of Syphilis:
Gram-positive cocci identified via microscopy.
Person-to-person transmission confirmed.
Fluorescent Antibody Staining: Uses antibodies labeled to identify T. pallidum in microscopy.
RPR Test: Cardioplipin antigen mixed with patient serum for diagnosis.
Natural/Innate Immunity
Mechanisms include skin, WBCs, macrophages, and various secretions (tears, mucus, etc.).
Haptens: Nonimmunogenic substances that require a carrier to incite an immune response.
Immunoglobulin Across Placenta: Primarily IgG.
B Cells: Produce humoral antibodies as part of acquired immunity.
Hybridoma Technology: Combines cancerous cells with antibody-producing cells for sustained antibody production.
MHC Class I: Present on all nucleated cells; involved in immune recognition.
Immunoglobulin A (IgA): Present in mucosal secretions; important for immune response at mucosal surfaces (milk, saliva, tears).
Humoral Immune Response
Involves B cells and plasma cells producing antibodies.
Th2 Cells: Produce IL-4, IL-10; key in antibody-related immunity and regulation regarding allergies and autoimmunity.
Cytokines:
IL-1: Attracts immune cells and acts as an endogenous pyrogen.
IL-3/IL-7: Involved in hematopoiesis.
Cell Signaling
Autocrine: Cytokines act on the cell that released them (e.g., IL-1β).
TGF-B: Regulates cell growth and limits activated cell expansion.
Lymphocytes: Essential for recognizing distinct antigenic determinants.
Erythropoietin (EPO): A cytokine used to treat severe anemia; affects hypothalamus to induce fever in response to infections.